Dr. Reddy's: Newspaper notice on unclaimed dividend and shares transfer to IEPF
Dr. Reddy's Laboratories is transferring unclaimed dividends and shares to the IEPF by August 30, 2026. Shareholders with unpaid dividends from FY 2018-19 onwards are urged to claim by this date. The notice is published in Business Standard and Nava Telangana.
This is a routine compliance announcement regarding the transfer of unclaimed dividends and shares to the IEPF. It does not involve any new business, financial, or strategic developments that would significantly impact the company's operations or stock price.
The announcement is a routine regulatory filing regarding the transfer of unclaimed dividends and shares to the IEPF, which is a standard compliance procedure. It does not contain any financial performance data or strategic business updates that would indicate a positive or negative sentiment.
Dr. Reddy's Laboratories Limited has published a notice regarding the transfer of unclaimed dividends and underlying equity shares to the Investor Education and Protection Fund (IEPF). This action is being taken in accordance with Section 124(6) of the Companies Act, 2013, and related rules.
The company has sent individual notices to shareholders whose dividends have remained unpaid or unclaimed for seven consecutive years, specifically for the financial year 2018-19 and subsequent years. These shareholders are advised to claim their dividends on or before August 30, 2026.
Details of shareholders whose dividends are unclaimed and shares are due for transfer are available on the company's website, www.drreddys.com. Shareholders can contact the Company's Registrar & Share Transfer Agent, M/s. Bigshare Services Private Limited, or the Company directly before August 30, 2026, to make a valid claim. If no claim is made by this date, the shares will be transferred to the IEPF Authority's account.
Shareholders whose shares and unpaid dividends have already been transferred to the IEPF can claim them by submitting an online application (IEPF-5) on the IEPF website (www.iepf.gov.in) and sending a physical copy to the Company's Nodal Officer. It is important to note that after the transfer of unpaid/unclaimed dividends and shares to the IEPF, no claims will be entertained by Dr. Reddy's Laboratories Limited.
This notice is also accessible on the websites of Dr. Reddy's Laboratories, BSE (www.bseindia.com), and NSE (www.nseindia.com).
What to do with a filing like this
Dr. Reddy's Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Dr. Reddy's Laboratories Limited. Read the original for the full detail.